MedTrace Logo

Lifestyle Modification for the Treatment of Symptomatic Atrial Fibrillation (LIFE-AF)

NCT03785418 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2018-12-26

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effectiveness of a lifestyle modification intervention focused on healthy eating, regular exercise and behavioural therapy to decrease the length and number of atrial fibrillation episodes as well as gain an understanding of the impact of these changes on the gut microbiome.

Conditions

Interventions

BEHAVIORAL

Multicomponent Risk Factor Modification

Healthy eating, regular exercise and behavioural therapy.

Sponsors & Collaborators

  • Abbott

    collaborator INDUSTRY

  • University of Toronto

    collaborator OTHER

  • Dr. Benedict Glover

    lead OTHER

Principal Investigators

  • Benedict M Glover, MD · Queen's University

  • Christopher Simpson, MD · Queen's Unviersity

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-29
Primary Completion
2020-07-31
Completion
2020-07-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03785418 on ClinicalTrials.gov